Ingrid Hedenfalk

21 – 30 of 98

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/onk-ifa?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
10
next »

2021
Mark Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila ^LU ; Akrap, Nina ^LU ; Staaf, Johan ^LU ; Alves, Carla L ; Ehinger, Anna ^LU ; Ebbesson, Anna ^LU ; Hedenfalk, Ingrid ^LU ; Beumers, Lukas ^LU ; Veerla, Srinivas ^LU and Harbst, Katja ^LU , et al. (2021) In Breast cancer research : BCR 23(1). p.26-26
- Contribution to journal › Article
Mark Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
Stenström, Jenny ; Hedenfalk, Ingrid ^LU and Hagerling, Catharina ^LU (2021) In Breast Cancer Research 23(1).
- Contribution to journal › Article
Mark Homologous recombination repair mechanisms in serous endometrial cancer
Jönsson, Jenny Maria ^LU ; Bååth, Maria ^LU ; Björnheden, Ida ; Sahin, Irem Durmaz ^LU ; Måsbäck, Anna ^LU and Hedenfalk, Ingrid ^LU (2021) In Cancers 13(2).
- Contribution to journal › Article
Mark Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
Bayani, Jane ; Poncet, Coralie ; Crozier, Cheryl ; Neven, Anouk ; Piper, Tammy ; Cunningham, Carrie ; Sobol, Monika ; Aebi, Stefan ; Benstead, Kim and Bogler, Oliver , et al. (2021) In npj Breast Cancer 7(1).
- Contribution to journal › Article
Mark Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
Martin de la Fuente, Laura ^LU ; Li, Minerva ^LU ; Veerla, Srinivas ^LU and Hedenfalk, Ingrid ^LU (2021)
- Contribution to conference › Poster
2020
Mark PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura ^LU ; Westbom-Fremer, Sofia ^LU ; Arildsen, Nicolai Skovbjerg ^LU ; Hartman, Linda ^LU ; Malander, Susanne ^LU ; Kannisto, Päivi ^LU ; Måsbäck, Anna ^LU and Hedenfalk, Ingrid ^LU (2020) In Virchows Archiv: an international journal of pathology 477(1). p.83-91
- Contribution to journal › Article
Mark A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
Leandersson, Pia ^LU ; Åkesson, Anna ^LU ; Hedenfalk, Ingrid ^LU ; Malander, Susanne ^LU and Borgfeldt, Christer ^LU (2020) In PLoS ONE 15(10 October).
- Contribution to journal › Article
Mark Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
Arildsen, Nicolai Skovbjerg ^LU and Hedenfalk, Ingrid ^LU (2020) In Oncotarget 11(40). p.3660-3674
- Contribution to journal › Article
Mark High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
Corvigno, Sara ; Mezheyeuski, Artur ; De La Fuente, Laura Martin ^LU ; Westbom-Fremer, Sofia ^LU ; Carlson, Joseph W. ; Fernebro, Josefin ^LU ; Åvall-Lundqvist, Elisabeth ; Kannisto, Paivi ^LU ; Hedenfalk, Ingrid ^LU and Malander, Susanne ^LU , et al. (2020) In Gynecologic Oncology 159(3). p.860-868
- Contribution to journal › Article
Mark SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Bååth, Maria ^LU ; Westbom-Fremer, Sofia ^LU ; Martin de la Fuente, Laura ^LU ; Ebbesson, Anna ^LU ; Davis, Juliette ; Malander, Susanne ^LU ; Måsbäck, Anna ^LU ; Kannisto, Päivi ^LU and Hedenfalk, Ingrid ^LU (2020) In Molecular and Cellular Oncology 7(6).
- Contribution to journal › Article

« previous
1
2
3
4
5
…
10
next »